496 CD47 expression as a predictive biomarker for evorpacept in HER2-positive gastric/gastroesophageal cancer from the Phase 2 randomized ASPEN-06 trial
Zev A. Wainberg, Keun‐Wook Lee(Seoul National University Bundang Hospital), Josep Tabernero(Vall d'Hebron Hospital Universitari), Eric Van Cutsem(Universitair Ziekenhuis Leuven), Clélia Coutzac(Centre Léon Bérard), Christelle de la Fouchardière(Institut Paoli-Calmettes), Jeeyun Lee(Samsung Medical Center), Sun Young Rha(Yonsei University), Yoon‐Koo Kang(Asan Medical Center), Charlie Zhang(Alector (United States)), Daniel Brickman(Alector (United States)), Philip Fanning(Alector (United States)), Alison Forgie(Alector (United States)), Athanasios C. Tsiatis(Alector (United States)), Alan Sandler(Alector (United States)), Kohei Shitara(National Cancer Center Hospital East)
Cited by 0Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis